| Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology M Suárez-Calvet, E Morenas-Rodríguez, G Kleinberger, K Schlepckow, ... Molecular neurodegeneration 14, 1-14, 2019 | 221 | 2019 |
| CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM 2, neurodegeneration and cognitive decline M Suárez‐Calvet, A Capell, MÁ Araque Caballero, E Morenas‐Rodríguez, ... EMBO molecular medicine 10 (12), e9712, 2018 | 89 | 2018 |
| Astrocyte-and neuron-derived extracellular vesicles from Alzheimer’s disease patients effect complement-mediated neurotoxicity CJ Nogueras-Ortiz, V Mahairaki, F Delgado-Peraza, D Das, K Avgerinos, ... Cells 9 (7), 1618, 2020 | 80 | 2020 |
| Sulforaphane inhibits lipopolysaccharide-induced inflammation, cytotoxicity, oxidative stress, and miR-155 expression and switches to Mox phenotype through activating … E Eren, KU Tufekci, KB Isci, B Tastan, K Genc, S Genc Frontiers in immunology 9, 36, 2018 | 78 | 2018 |
| Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease J Blommer, T Pitcher, M Mustapic, E Eren, PJ Yao, MP Vreones, ... Brain 146 (1), 195-208, 2023 | 60 | 2023 |
| Extracellular vesicle biomarkers of Alzheimer's disease associated with sub‐clinical cognitive decline in late middle age E Eren, JFV Hunt, M Shardell, S Chawla, J Tran, J Gu, NM Vogt, ... Alzheimer's & Dementia 16 (9), 1293-1304, 2020 | 60 | 2020 |
| Mitochondrial RNA in Alzheimer’s disease circulating extracellular vesicles KM Kim, Q Meng, O Perez de Acha, M Mustapic, A Cheng, E Eren, ... Frontiers in cell and developmental biology 8, 581882, 2020 | 49 | 2020 |
| Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study N Kruse, S Persson, D Alcolea, JMC Bahl, I Baldeiras, E Capello, ... Neurobiology of aging 36 (9), 2587-2596, 2015 | 35 | 2015 |
| Mitochondrial electron transport chain protein abnormalities detected in plasma extracellular vesicles in Alzheimer’s disease PJ Yao, E Eren, EJ Goetzl, D Kapogiannis Biomedicines 9 (11), 1587, 2021 | 31 | 2021 |
| Neuronal-derived EV biomarkers track cognitive decline in Alzheimer’s disease E Eren, JM Leoutsakos, J Troncoso, CG Lyketsos, ES Oh, D Kapogiannis Cells 11 (3), 436, 2022 | 27 | 2022 |
| Mitochondrial protrusions in neuronal cells PJ Yao, E Eren, RS Petralia, JW Gu, YX Wang, D Kapogiannis Iscience 23 (9), 2020 | 20 | 2020 |
| MicroRNA exocytosis by large dense-core vesicle fusion A Gümürdü, R Yildiz, E Eren, G Karakülah, T Ünver, Ş Genç, Y Park Scientific reports 7 (1), 45661, 2017 | 20 | 2017 |
| Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer’s disease: novel methodology and clinical proof of concept E Eitan, T Thornton-Wells, K Elgart, E Erden, E Gershun, A Levine, ... Extracellular vesicles and circulating nucleic acids 4 (1), 133, 2023 | 17 | 2023 |
| I. Alzheimer's Disease Neuroimaging (2019).“Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-beta … M Suarez-Calvet, E Morenas-Rodriguez, G Kleinberger, K Schlepckow, ... Mol Neurodegener 14 (1), 1, 0 | 14 | |
| Improved cerebrospinal fluid-based discrimination between Alzheimer’s disease patients and controls after correction for ventricular volumes LJC Van Waalwijk Van Doorn, JD Gispert, HB Kuiperij, JAHR Claassen, ... Journal of Alzheimer's Disease 56 (2), 543-555, 2017 | 11 | 2017 |
| Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model C Tallon, BJ Bell, MM Malvankar, P Deme, C Nogueras-Ortiz, E Eren, ... Translational Neurodegeneration 12 (1), 56, 2023 | 5 | 2023 |
| Novel modification of Luminex assay for characterization of extracellular vesicle populations in biofluids OV Volpert, E Gershun, K Elgart, V Kalia, H Wu, AA Baccarelli, E Eren, ... BioRxiv, 2022.01. 12.475897, 2022 | 5 | 2022 |
| Single‐extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron‐derived EVs CJ Nogueras‐Ortiz, E Eren, P Yao, E Calzada, C Dunn, O Volpert, ... Journal of Extracellular Vesicles 13 (6), e12459, 2024 | 4 | 2024 |
| Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer’s disease C Tallon, BJ Bell, MM Malvankar, P Deme, C Nogueras-Ortiz, E Eren, ... Research Square, 2023 | 3 | 2023 |
| Examination of IL-1 beta level as an inflammasome marker in Alzheimer's disease O Bulut, A Tanburoglu, G Boluk, N Demir, E Eren, U Vurgun, S Genc, ... | 2 | 2019 |
